Jobs / United States / Iovance Biotherapeutics INC

Iovance Biotherapeutics INC

AI Product Engineer

Remote · Remote · region not stated Posted 4 days ago

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Skills this job asks for

JavaScriptReactNode.jsPythonLLMsCI/CD

Add your CV (free) to see which of these your CV is missing.

Where you can work from

Location not specified

The listing does not say where you can work from. Missing information is not the same as worldwide: check before applying.

The company's headquarters is not the same as where you may work from. Visa sponsorship only matters if you would relocate; see below.

Visa sponsorship, if you would relocate

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

About   Iovance Biotherapeutics, Inc.   Iovance Biotherapeutics , Inc.  is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The  Iovance TIL platform  spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit  www.iovance.com . Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on  www.iovance.com . Overview Iovance Biotherapeutics is a commercial-stage cell therapy company focused on developing life-saving cancer immunotherapies. We are building an internal AI Strategy & Operations function to drive measurable cost savings and operational efficiency across every department in the company. We are hiring an AI Product Engineer to build internal AI-enabled tools at Iovance. This is a hands-on full-stack JavaScript engineering role for someone who uses AI-assisted development to ship faster without compromising code quality, security, or maintainability. You will design, build, and deploy micro-applications and workflow automations that solve real business problems. You will join a single engineering team that serves every business function, working from a scored build queue. AI Strategists embedded in Commercial, Technical Operations, Clinical, R&D, and corporate functions bring validated use cases and working prototypes; you turn them into tools people use every day. The foundation of this role is engineering. The multiplier is AI fluency. You should be using tools like Claude, Cursor, Copilot to dramatically accelerate your workflow. We want a skilled engineer who produces significantly more output because of how they use AI. Essential Functions and Responsibilities • Rapidly prototype, build, and deploy AI-powered micro-applications using React (frontend) and Node.js/Python (backend). • Take prototypes and proof-of-concepts from AI Strategists and convert them into production-ready tools. • Build lightweight, single-purpose tools designed for low ongoing maintenance. Every application should be simple enough that it runs with minimal support. • Use AI tools (Claude, Copilot, Cursor, and similar) to accelerate every stage of your workflow - prototyping, code generation, debugging, documentation. • Test and evaluate LLM outputs for accuracy, design safeguards against hallucination and misuse, and include human-in-the-loop review wherever outputs inform business, quality, or regulatory decisions. • Own the CI/CD pipeline for your applications: automate build, test, and deployment using version control, with automated testing and security checks. • Work directly with business stakeholders to understand their pain points, translate them into technical solutions, and iterate based on real user feedback. • Build reusable

Apply on employer site ↗